A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/02/2011	CN102229660A Truncated human papillomavirus 33 type L1 protein
11/02/2011	CN102229648A HLA-A*0201 restrictive CTL (cytotoxic T lymphocyte) epitope for tumor antigen Pokemon and application thereof
11/02/2011	CN102229640A Application of triterpenoid saponins compound extracted from anemone taipaiensis
11/02/2011	CN102229636A New derivatives of berberine coupled with cholic acid at ninth position through ester bond and preparation methods thereof
11/02/2011	CN102229611A 2,6-diaryl pyrazolo[1,5-a]pyrazine-4(5H)-ketone compound and its application
11/02/2011	CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011	CN102229598A Mapping-agathis dammara type diterpene compound, and preparation method and application thereof
11/02/2011	CN102229595A Sesquiterpenoids in Cordyceps Ophioglossoides and use thereof
11/02/2011	CN102229588A Briarane type diterpenoid compounds with anti-tumor and antibacterial activities and application thereof
11/02/2011	CN102229585A [Gamma]-butyrolactone polyketone compounds with antitumor activities
11/02/2011	CN102229572A 3-fluorophenyl-quinazoline-4 (3H)-ketone compound and preparation method thereof
11/02/2011	CN102229563A 4-amino quinoline derivative, preparation method and application thereof
11/02/2011	CN102229546A 1,4-pentadiene-3-ketone compound including sulfonic acid ester group, preparation method and use thereof
11/02/2011	CN102228698A HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof
11/02/2011	CN102228689A In vitro cancer therapy compound identification method
11/02/2011	CN102228653A Ethanol extract of galangal fruit and medical application thereof
11/02/2011	CN102228599A Chinese medicinal preparation for treating tumor
11/02/2011	CN102228593A Chinese herbal medicine prescription for treating esophagus cancer, and preparation method thereof
11/02/2011	CN102228515A Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
11/02/2011	CN102228506A Composition of malaytea scurfpea extract as well as preparation method and use thereof
11/02/2011	CN102228504A Formula of anticancer Chinese medicine and process for preparing products of anticancer Chinese medicine
11/02/2011	CN102228499A Method for separating naphthoquinone active ingredients from sinkiang arnebia root
11/02/2011	CN102228494A Traditional Chinese medicine composition for supporting healthy energy, strengthening human body immunity, resisting fatigue and tumors, and delaying aging
11/02/2011	CN102228489A Method for extracting total saponins of panax notoginseng from graecum hance
11/02/2011	CN102228488A Preparation of Lysimachia capillipes Hemsl total saponin
11/02/2011	CN102228487A Extraction method for saponin from Stauntonia brachyanthera Hand-Mazz
11/02/2011	CN102228483A Freeze-dried preparation of xanthone anti-tumour medicine and preparation method thereof
11/02/2011	CN102228478A Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof
11/02/2011	CN102228455A Application of bisbibenzyl compound to preparation of anti-inflammatory medicament
11/02/2011	CN102228452A Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
11/02/2011	CN102228442A Star-like macromolecule nanometer microsphere and preparation method and application thereof
11/02/2011	CN102228437A Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof
11/02/2011	CN102228433A Supersaturated self-microemulsion as well as preparation method and application thereof
11/02/2011	CN102228431A Self-emulsified medicinal composition for taxane compounds
11/02/2011	CN102228430A Nano-suspension for silybin-phospholipid complex and preparation method thereof
11/02/2011	CN102228425A Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof
11/02/2011	CN102228424A Drug sustained-release system for treating tumours and preparation method thereof
11/02/2011	CN101759644B Crystalline form III of Lonidamine and preparation method thereof and composition containing same
11/02/2011	CN101695502B Lanthanum fullerenol and application in preparing medicaments for inhibiting tumor growth
11/02/2011	CN101648921B Benzamide compound used as histone deacetylase inhibitor and application thereof
11/02/2011	CN101642462B Tumor inhibitor NRN1SR42
11/02/2011	CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof
11/02/2011	CN101514174B Method for extracting multifunctional sulforaphane from broccoli sprouting vegetable
11/02/2011	CN101511798B [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
11/02/2011	CN101385860B Camptothecine and non-linear polyethyleneglycol prodrug of derivative thereof
11/02/2011	CN101104078B Polypeptide and protein medicine polyethylene coupling compound
11/02/2011	CN101058573B 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
11/02/2011	CN101003470B Analog of mono carbonyl structure of curcumin, and usage
11/01/2011	US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048428 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	CA2605205C Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
11/01/2011	CA2521854C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
11/01/2011	CA2452986C Use of polyclonal anti-hiv goat serum as a therapeutic agent
11/01/2011	CA2434526C Methods of administering epothilone analogs for the treatment of cancer
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2203622C Compounds, pharmaceutical composition and diagnostic device comprising them and their use
10/2011
10/27/2011	WO2011133983A2 Reishi polysaccharide-based compositions and methods for treatment of cancer
10/27/2011	WO2011133925A2 Targeted and light-activated cytosolic drug delivery
10/27/2011	WO2011133886A2 Production of heteromultimeric proteins
10/27/2011	WO2011133879A2 Combination therapies with mitochondrial-targeted anti-tumor agents
10/27/2011	WO2011133875A2 Metalloenzyme inhibitor compounds
10/27/2011	WO2011133867A2 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
10/27/2011	WO2011133858A2 Compositions, methods of use, and methods of treatment
10/27/2011	WO2011133827A2 Method of treating prostate cancer
10/27/2011	WO2011133826A2 Method for treating pancreatic cancer
10/27/2011	WO2011133819A2 Methods of enhancing antibody-dependent cellular cytotoxicity
10/27/2011	WO2011133795A2 Beta-carbolines as inhibitors of haspin and dyrk kinases
10/27/2011	WO2011133773A2 Compositions and methods for leukocyte-targeting multi-valent imaging probes
10/27/2011	WO2011133673A1 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
10/27/2011	WO2011133659A2 Inhibitors of hif and angiogenesis
10/27/2011	WO2011133637A2 Compounds and methods for kinase modulation, and indications therefor
10/27/2011	WO2011133584A2 Nucleic acid compounds for inhibiting hras gene expression and uses thereof
10/27/2011	WO2011133555A2 Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration
10/27/2011	WO2011133520A1 Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
10/27/2011	WO2011133512A1 Rtef-1 variants and uses thereof
10/27/2011	WO2011133480A2 Method of treating gastric cancer
10/27/2011	WO2011133479A2 Combination therapy with a proteasome inhibitor and a gallium complex
10/27/2011	WO2011133475A2 Compositions and method for the treatment of multiple myeloma
10/27/2011	WO2011133424A2 Genetic amplification of iqgap1 in cancer
10/27/2011	WO2011133388A1 Pyrrolopyridine inhibitors of kinases
10/27/2011	WO2011133210A2 A method treating breast cancer
10/27/2011	WO2011133039A2 Novel conjugates of cc-1065 analogs and bifunctional linkers
10/27/2011	WO2011132967A2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
10/27/2011	WO2011132955A2 Use of hades as tumor suppressor target
10/27/2011	WO2011132713A1 Lipid membrane structure with nuclear transferability
10/27/2011	WO2011131925A2 Osmium (ii) arene azo anti-cancer complexes
10/27/2011	WO2011131912A1 Magneto-optical nano-objects for cancer detection
10/27/2011	WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011	WO2011131709A1 Furopyridine compounds and uses thereof
10/27/2011	WO2011131697A1 Lysine specific demethylase-1 inhibitors and their use
10/27/2011	WO2011131636A1 Combined treatment of cancer with benzo[e]pyridoindoles and dna-damaging agents

1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 2211